ImmuneSupport.com is now ProHealth.com


transparent gif
ImmuneSupport.com Home  
Regional cerebral blood flow between primary and concomitant Fibromyalgia patients:
A possible way to differentiate concomitant Fibromyalgia from the primary disease
Fibromyalgia & Chronic Fatigue Syndrome Home Page Fibromyalgia & Chronic Fatigue Syndrome Library Fibromyalgia & Chronic Fatigue Syndrome Treatment and Research Email bulletins Fibromyalgia & Chronic Fatigue Syndrome Products Fibromyalgia & Chronic Fatigue Syndrome Community Area Fibromyalgia & Chronic Fatigue Syndrome About Us transparent gif transparent gif
transparent gif
Health Watch Newsletter background The Latest News Articles background The Latest Abstracts background The Latest Drug News background
Search Our Site
 
Home
Fibromyalgia Resources

Chronic Fatigue Syndrome Resources

E-mail Bulletin
Store
Community
About Us

Your Support Funds Research & Advocacy

Regional cerebral blood flow between primary and concomitant Fibromyalgia patients: A possible way to differentiate concomitant Fibromyalgia from the primary disease


by JJ Chen, et al.
ImmuneSupport.com


08-17-2007

Advertisement
Objectives: Technetium-99m ethyl cysteinate dimer (Tc-99m ECD) brain single photon emission computed tomography (SPECT) has been used to detect abnormal regional cerebral blood flow (rCBF) in women with primary Fibromyalgia (FM). The main aim of this study was to investigate the rCBF deficit in concomitant FM patients and compare it with primary FM.

Methods: An observational study was designed to analyse the SPECT findings in 92 female patients recruited from January 2002 to January 2004.

Differences in the rCBF hypoperfusive areas between 49 primary and 29 concomitant FM patients were assessed in different areas of the brain using the chi(2)-test for statistical significance.

Results: Tc-99m ECD brain SPECT in 71 FM patients revealed heterogeneous rCBF in comparison to the homogeneous scan in 14 control patients. The most prominent rCBF hypoperfusive region in both primary and concomitant FM groups was the left temporoparietal area, followed by the thalamus, right temporoparietal, frontal, and basal ganglia areas. Differences in rCBF hypoperfusion in these areas for both FM groups were not significant (all p>0.5).

Conclusions: Reduced rCBF at cortical regions, in addition to previously reported areas at the thalamus and the subcortical nucleus, in FM patients was demonstrated in this study.

The perfusion deficit areas were similar between primary and concomitant FM when the underlying disease activity was quiescent.

The feasibility of using this neuroimaging study to differentiate FM from the primary disease, such as rheumatoid arthritis (RA)-associated depression and neuropsychiatric lupus, should be considered.

Source: Scandanavian Journal of Rheumatology. 2007 May-Jun;36(3):226-32. PMID: 17657679, by Chen JJ, Wang JY, Chang YM, Su SY, Chang CT, Sun SS, Kao CH, Lee CC. Section of Rheumatology, Department of Internal Medicine, China Medical University Hospital, Taichung, China.

  Newsletter SignUp Discuss (0 comments) Email Article Print Page
Related Articles:
The propensity of different Borrelia burgdorferi sensu stricto genotypes to cause disseminated infections in humans – Source: American Journal of Tropical Medicine and Hygiene, May 2008
Rating of 2.9
Gene Expression Subtypes in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis – Source: Journal of Infectious Diseases, Apr 2008
Rating of 3.2
Is Chronic Fatigue Syndrome caused by a rare brain infection of a common, normally benign virus? - Source: Medical Hypotheses, Apr 24 2008
Rating of 3
Chronic Fatigue Syndrome in male Gulf War veterans and civilians: A further test of the single syndrome hypothesis [Source: Journal of Health Psychology, May 2008]
Rating of 3.1
Lactulose breath testing does not discriminate patients with Irritable Bowel Syndrome from Healthy Controls - Source: American Journal of Gastroenterology, Apr 2008
Rating of 2.7

Every purchase funds research, donations and the community resources provided within our website.

Powerful immune support
Transfer Factor System 200™

Stimulate and enhance your immune system
Transfer Factor System 100™

Grab the single most potent dose of Vitamin D on the market
D3 Extreme™

Give your body a boost
Vitamin D3 5000™

Protection from heat fatigue
BioSalt Tabs™

At ProHealth we believe in "commerce with compassion."

Weekly Special





[ Be the first to comment on this article ]
DISCUSS THIS ARTICLE  (0 existing comments)
Post a Comment
transparent gif
transparent gif transparent gif transparent gif

Home | Library | Email Bulletins | Store | Community | Affiliates


ProHealth's ImmuneSupport.com- The World's Largest Fibromyalgia & Chronic Fatigue Syndrome Website!
Email US or Call US at 1-800-366-6056
Monday-Friday, 7 a.m.-5 p.m. PST
International Callers can reach us at 001.805.564.3064
Copyright © 2008 ProHealth, Inc.
About us, Affiliates, Careers, Contact us, Privacy, 30-day Money Back Guarantee